The Spiration Valve System for the Treatment of Severe Emphysema (REACH)
Sponsor: Olympus Corporation
Listed as NCT01989182, this NA trial focuses on Empyhsema and Pulmonary Disease, Chronic Obstructive and remains completed. Sponsored by Olympus Corporation, it has been updated 9 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Oct 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Oct 2023 [monthly]
Completed NA
-
Jun 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 4 earlier versions
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
-
Jun 2017 — Mar 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Feb 2017 — Jun 2017 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Olympus Corporation
- Olympus Corporation of the Americas
- Tigermed Consulting Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .